AbbVie Inc. (ABBV) Gets Downgraded to Peer Perform From Outperform by Wolfe Research

1 week ago 4

Noor Ul Ain Rehman

Sat, January 10, 2026 astatine 1:57 PM CST 2 min read

AbbVie Inc. (NYSE:ABBV) is 1 of the champion performing pharma stocks successful 2025. AbbVie Inc. (NYSE:ABBV) was downgraded to Peer Perform from Outperform connected January 8 by Wolfe Research without a terms target. The steadfast stated that the shares already bespeak outperformance expectations successful Skyrizi and Rinvoq, which is wherefore it is moving to the sidelines waiting for higher visibility connected the company’s immunology and inflammation “encore” and competitory dynamics.

BofA Cuts AbbVie (ABBV) Target While Maintaining Neutral View

In a abstracted development, Reuters reported connected January 7 that AbbVie Inc. (NYSE:ABBV) denied its engagement successful talks for the acquisition of Revolution Medicines. The update came aft the Wall Street Journal reported that AbbVie Inc. (NYSE:ABBV) was successful precocious discussions to bargain Revolution Medicines, the cancer-drug developer. AbbVie Inc. (NYSE:ABBV) told Reuters successful an emailed connection that it “is not successful discussions with Revolution Medicines”.

The aforesaid day, UBS assumed sum of AbbVie Inc. (NYSE:ABBV) with a Neutral rating, lifting the terms people connected the banal to $240 from $220. It told investors that it believes the institution is reasonably priced astatine existent levels, and sees a balanced risk/reward for the company’s shares arsenic contention emerges for its blockbuster immunology drugs Skyrizi and Rinvoq successful 2026 and 2027.

AbbVie Inc. (NYSE:ABBV) is simply a research-based pharmaceutical institution that develops and sells products to dainty chronic diseases successful oncology, gastroenterology, rheumatology, dermatology, virology, and assorted different superior wellness conditions.

While we admit the imaginable of ABBV arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.